Search results
Misleading Claims on Well-Known Rare Risk of AstraZeneca COVID-19 Vaccine - FactCheck.org
FactCheck.org· 12 hours agoA rare risk of dangerous blood clots associated with the AstraZeneca COVID-19 vaccine was identified and reported in early 2021. This ...
Free COVID-19 vaccines could be a thing of the past as federal program is set to expire early
Chicago Sun-Times· 1 day agoWhen COVID-19 vaccines entered the commercial market, the federal government introduced a program to...
Small uptick in Ohio COVID-19 cases ends 13-week streaking of falling cases: Coronavirus update
The Cleveland Plain Dealer· 13 hours agoThere were 34 Ohioans newly hospitalized with COVID-19 in the last week, raising the total since the beginning of the pandemic in 2020 to 151,526.
New COVID-19 'FLiRT' Variants Are The Most Dominant In The U.S.
Women's Health via Yahoo News· 3 days agoThe FDA and CDC will meet on June 5 to make recommendations "on the strain(s) to be included in the...
Sarasota Memorial Hospital board will consider adopting Ladapo's anti-vaccine guidance
Herald-Tribune via Yahoo News· 4 days agoThis is what Ladapo claims about mRNA Covid-19 vaccines In January, Ladapo questioned the safety of...
Covid jab technology-based bird flu vaccine may help curb H5N1 cases
Investing.com· 2 hours agoNew Delhi, May 24 (IANS) Amid the global rise in H5N1 cases, US scientists have developed an...
Vaccines not blamed for new cardiovascular-kidney-metabolic syndrome | Fact check
USA TODAY via Yahoo News· 14 hours agoThe organization did not make any announcement tying the findings to vaccines, and COVID-19 vaccines...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
Could current COVID vaccines protect against future outbreaks? New study offers hope
Orange County Register· 15 hours agoA group of researchers had the future in mind when they asked if current COVID-19 vaccines and...
Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027
Reuters via Yahoo Finance· 2 days agoInvestors have fled from Pfizer as pandemic worries declined and billions of dollars in COVID-19 ...